Market Place
Market Place
Post Enquiry
Analyzing over US$ 90 billion of Medicare Prescription Drug (Part D) Spending in 2016
This week, PharmaCompass
reviews the recently released data on prescription drugs paid for under th
Top drugs by sales in 2017: Who sold the blockbuster drugs?
The year 2017 was a landmark year for pharmaceutical
industries in the US and Europe, with a sharp i
Drug costs and prescription trends in the United States: Analyzing Medicare’s $121 billion spend
In less than three weeks, Donald Trump will assume office as the
President of the United States. He
Ranbaxy’s path of deception revealed in Singapore court order; Chinese, Indian, American and Spanish firms in compliance troubles
This week, Phispers brings you the
latest on the Ranbaxy-Daiichi and Merck-Gilead cases. There is al
GSK, Google form first bioelectronics firm; 11 generic companies benefit from the Teva Allergan deal
This week,
Phispers brings to you the details of the bioelectronics firm formed by GSK and
Google. T
Faster drug approvals in the U.S. through the 21st Century Cures Act
The proposed overhaul of the U.S. drug
approval system through the 21st
Century Cures Act won’
Merck vs Merck: A ‘Mercky’ tale
It doesn’t help that the company, which calls
itself Merck in the United States isn’t al
